Nir Giladi

3.9k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Nir Giladi is a scholar working on Neurology, Neurology and Pharmacology. According to data from OpenAlex, Nir Giladi has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 5 papers in Neurology and 4 papers in Pharmacology. Recurrent topics in Nir Giladi's work include Neurological disorders and treatments (12 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Nir Giladi is often cited by papers focused on Neurological disorders and treatments (12 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Nir Giladi collaborates with scholars based in Israel, United States and Canada. Nir Giladi's co-authors include Jeffrey M. Hausdorff, Daniel Roggen, Gerhard Tröster, Marc Bächlin, Inbal Maidan, Meir Plotnik, Amos D. Korczyn, Shraga Hocherman, Ruth Djaldetti and Diana Paleacu and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Journal of neurosurgery.

In The Last Decade

Nir Giladi

31 papers receiving 1.0k citations

Hit Papers

Wearable Assistant for Pa... 2009 2026 2014 2020 2009 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nir Giladi 486 284 206 167 158 32 1.1k
Spiros Konitsiotis 993 2.0× 213 0.8× 111 0.5× 74 0.4× 616 3.9× 51 2.2k
Álvaro Sánchez‐Ferro 1.0k 2.1× 198 0.7× 194 0.9× 50 0.3× 236 1.5× 59 1.7k
Karin Srulijes 882 1.8× 175 0.6× 217 1.1× 85 0.5× 182 1.2× 27 1.3k
Amie Peterson 403 0.8× 150 0.5× 214 1.0× 20 0.1× 154 1.0× 11 894
Mark V. Albert 111 0.2× 277 1.0× 175 0.8× 314 1.9× 29 0.2× 57 1.1k
Carlo Maremmani 467 1.0× 237 0.8× 125 0.6× 34 0.2× 95 0.6× 28 844
Jinse Park 464 1.0× 123 0.4× 96 0.5× 21 0.1× 178 1.1× 85 1.4k
Michelle A. Burack 575 1.2× 144 0.5× 70 0.3× 36 0.2× 329 2.1× 30 1.2k
Venkateswaran Rajagopalan 281 0.6× 106 0.4× 24 0.1× 93 0.6× 46 0.3× 42 778
Ruth B. Schneider 478 1.0× 83 0.3× 73 0.4× 23 0.1× 95 0.6× 33 889

Countries citing papers authored by Nir Giladi

Since Specialization
Citations

This map shows the geographic impact of Nir Giladi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Giladi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Giladi more than expected).

Fields of papers citing papers by Nir Giladi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nir Giladi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Giladi. The network helps show where Nir Giladi may publish in the future.

Co-authorship network of co-authors of Nir Giladi

This figure shows the co-authorship network connecting the top 25 collaborators of Nir Giladi. A scholar is included among the top collaborators of Nir Giladi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nir Giladi. Nir Giladi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilat, Moran, Jorik Nonnekes, Stewart A. Factor, et al.. (2026). An updated definition of freezing of gait. Nature Reviews Neurology. 22(3). 172–181.
2.
Kurolap, Alina, Israela Lerer, Judith Dagan, et al.. (2022). Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon. Journal of Molecular Neuroscience. 72(8). 1715–1723. 2 indexed citations
3.
Bregman, Noa, et al.. (2021). Associations between visual hallucinations and impaired visuo-spatial abilities in dementia with Lewy bodies.. Neuropsychology. 35(3). 276–284. 4 indexed citations
4.
Peretz, Chava, Violetta Rozani, Nir Giladi, et al.. (2019). The Modifying Effect of Age on Survival in Parkinson’s Disease: A Population-Based Cohort Study. Neuroepidemiology. 53(1-2). 13–19. 7 indexed citations
5.
Giladi, Nir, et al.. (2019). The Added Value of 18F-FDOPA PET/CT in the Work-Up of Patients with Movement Disorders. Neurographics. 9(5). 344–348. 4 indexed citations
6.
Tankus, Ariel, Anat Mirelman, Nir Giladi, Itzhak Fried, & Jeffrey M. Hausdorff. (2018). Pace of movement: the role of single neurons in the subthalamic nucleus. Journal of neurosurgery. 130(6). 1–6. 4 indexed citations
7.
Balash, Yacov, Lihi Bar‐Lev Schleider, Amos D. Korczyn, et al.. (2017). Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience. Clinical Neuropharmacology. 40(6). 268–272. 56 indexed citations
8.
Peretz, Chava, Violetta Rozani, Tanya Gurevich, et al.. (2016). Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study. Clinical Neuropharmacology. 39(5). 227–231. 24 indexed citations
9.
Weiss, Aner, Eran Gazit, Ariel Tankus, et al.. (2015). Can a Body-Fixed Sensor Reduce Heisenberg’s Uncertainty When It Comes to the Evaluation of Mobility? Effects of Aging and Fall Risk on Transitions in Daily Living. The Journals of Gerontology Series A. 71(11). 1459–1465. 40 indexed citations
10.
Marder, Karen, Ming‐Xin Tang, Roy N. Alcalay, et al.. (2014). Age Specific Penetrance of the LRRK2 G2019S Mutation in the Michael J Fox Ashkenazi Jewish (AJ) LRRK2 Consortium (S17.002). Neurology. 82(10_supplement). 3 indexed citations
11.
Bächlin, Marc, Meir Plotnik, Daniel Roggen, et al.. (2009). Wearable Assistant for Parkinson’s Disease Patients With the Freezing of Gait Symptom. IEEE Transactions on Information Technology in Biomedicine. 14(2). 436–446. 498 indexed citations breakdown →
12.
Giladi, Nir. (2009). O.018 Mobility and exercise in movement disorders. Parkinsonism & Related Disorders. 15. S6–S6. 1 indexed citations
13.
Paleacu, Diana, et al.. (2004). Tetrabenazine Treatment in Movement Disorders. Clinical Neuropharmacology. 27(5). 230–233. 71 indexed citations
14.
Paleacu, Diana, et al.. (2001). Cross-Sectional Study of the Prevalence of Parkinson’s Disease in the Kibbutz Movement in Israel. Neuroepidemiology. 21(1). 50–55. 19 indexed citations
15.
Sirota, P., Nir Giladi, Herzel Shabtai, & Amos D. Korczyn. (2001). Dr. Sirota and Colleagues Reply. American Journal of Psychiatry. 158(4). 658–658. 2 indexed citations
16.
Sirota, P., et al.. (2000). Use of the Selective Serotonin 3 Receptor Antagonist Ondansetron in the Treatment of Neuroleptic-Induced Tardive Dyskinesia. American Journal of Psychiatry. 157(2). 287–289. 57 indexed citations
17.
Rabey, J. M., M. Huberman, E. Melamed, et al.. (2000). Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa. Clinical Neuropharmacology. 23(6). 324–330. 144 indexed citations
18.
Giladi, Nir & Eldad Melamed. (1999). Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism. Movement Disorders. 14(1). 158–159. 11 indexed citations
19.
Badarny, Samih, et al.. (1998). [Botulinum toxin injection effective for post-peripheral facial nerve palsy synkinesis].. PubMed. 135(3-4). 106–7, 167. 8 indexed citations
20.
Garty, I., Nir Giladi, & E Flatau. (1985). Bone scintigraphy in two siblings with pulmonary alveolar microlithiasis. British Journal of Radiology. 58(692). 763–766. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026